Authoritative Report on Emergency Department Experiences Rele...(ntly partners with more than 7000 health...),Health
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
NEWS
Authoritative Report on Emergency Department Experiences Released Today
ntly partners with more than 7000 health care facilities-- including over 40% of U.S. hospitals-to measure and improve the qualityof their care.
http://www.bio-medicine.org/inc/biomed/medicine-news.asp
http://feeds.bio-medicine.org/latest-medical-news
Date:6/9/2008
ntly partners with more than 7,000 health care facilities -- including over 40% of U.S. hospitals-to measure and improve the quality of their care.
'/>"/>
SOURCE Press Ganey Associates, Inc.
Copyright©2008
PR Newswire.
All rights reserved
0
GOOD
Page:
1
2
3
Related medicine news :
1
.
Virginia Tech Report Has National Importance
2
.
New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3
.
GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4
.
Haemacure Reports Third Quarter 2007 Results
5
.
Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6
.
Biotech Finishes on a High in August, Burrill Report Says
7
.
First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8
.
Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9
.
MDS Reports Third Quarter 2007 Results
10
.
First New York/New Jersey Health Care Report Card Released
11
.
Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*
Name:
*
Comment:
*
Email:
Breaking Medicine News(10 mins):
Health News:More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year 2
Health News:Clinical trial advances new approach to re-sensitizing breast cancer 2
Health News:Study shows how gene action may lead to diabetes prevention, cure 2
Health News:Better Vaccine Planning Needed, Committee Finds 2
Health News:Better Vaccine Planning Needed, Committee Finds 3
Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2
Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3
Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4
[
0
] More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year
[
0
] Clinical trial advances new approach to re-sensitizing breast cancer
[
0
] Study shows how gene action may lead to diabetes prevention, cure
[
0
] Better Vaccine Planning Needed, Committee Finds
[
0
] Effort to Regenerate Injured Spinal Cords Turns to a New Model
Other Medicine News:
Health News:Coffee Beans May Be Newest Stress-Buster 2
Health News:Coffee Beans May Be Newest Stress-Buster 3
Health News:Serum sodium predicts mortality 10 times higher in PAH patients 2
Health News:1 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9/11 2
Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 2
Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 3
Health News:AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill 2
Health News:AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill 3
Health News:New research shows how aging brain brings a healthy dose of perspective 2
Coffee Beans May Be Newest Stress-Buster
Serum sodium predicts mortality 10 times higher in PAH patients
1 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9/11
Caregivers Protest Foley & Lardner's Union Busting & Intimidation
AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill
New research shows how aging brain brings a healthy dose of perspective
Breaking Medicine Technology:
Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2
Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3
Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4
Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5
Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6
Dynatronics Receives 180-Day NASDAQ Extension 2
Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2
YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 1
YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 2
YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 3
OH2 Medical Spa Achieves the First U S LEED 28R 29 Certification for a Medical Commercial Interior 51691 1
OH2 Medical Spa Achieves the First U S LEED 28R 29 Certification for a Medical Commercial Interior 51691 2
Fitness Might Limit Strokes Impact 51687 1
Fitness Might Limit Strokes Impact 51687 2
[
0
] Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer
[
0
] Dynatronics Receives 180-Day NASDAQ Extension
[
0
] Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline
Other Medicine Technology:
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 2
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 3
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 4
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 5
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 6
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 7
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 2
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 3
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 4
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Medicine Products:
Codman Hakim Programmable Valve (CHPV) Micro with Rickham Reservoir
Osteopal V
Imagefusion Software
FrameLink Stereotactic Linking System
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health